Pharma Licensing: Explore differences between Royalty rate & Royalty base
Posted on25 Oct 2019
Comments0
Royalty rate : The appropriate royalty rate depends on numerous factors including the relative bargaining strength of the licensor and the licensee,... Read More
What is indication splitting licensing in pharmaceutical and bio-pharmaceutical business?
Posted on30 Sep 2019
Comments0
While licensing in pharmaceutical and bio pharmaceutical business, if licenses are issued to different partners based on indications or disease and therapy,... Read More
Pharma brand acquisition case study: Amgen to acquire Celgene’s Otezla
Amgen announced today that it has entered into an agreement with Celgene Corporation in connection with its previously announced merger with Bristol-Myers... Read More
In which class should be register the food supplement?
International trademark classes Food Supplement should be in class 5 (same class of pharmaceuticals). Major Class: Food supplements belongs to class 5 ... Read More
Case Study – A close look into Eli Lilly’s pricing strategy for Insulin Lispro injection in US market
Eli Lilly and Company’s has announced that its Insulin Lispro Injection is now available for order in pharmacies for people who use... Read More
Novatis’s Xiidra acquisition from Takeda for USD 5.3 billion
Novartis has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the assets associated with Xiidra (lifitegrast ophthalmic solution) 5%... Read More
Calixar licensing agreement with Regeneron
Calixar SAS, a biotechnology company specialized in native membrane protein stabilization, has entered into an exclusive licensing agreement with Regeneron Pharmaceuticals, Inc.... Read More
Sandoz licensing agreement with EirGenix to commercialize trastuzumab biosimilar
Posted on02 May 2019
TagsBiosimilar, biosimilar deals, biosimilar of sandoz, drug licensing, EirGenix, sandoz, trastuzumab
Comments0
Sandoz, a Novartis division and a global leader in biosimilars, has entered into an agreement to commercialize a proposed trastuzumab biosimilar. This... Read More
Glenmark to introduce SGLT2 inhibitor Remogliflozin in India by licesning collaboration with BHV Pharma
Glenmark Pharmaceuticals is bringing to India Remogliflozin etabonate, a drug used to treat adults with Type 2 diabetes. Glenmark did the phase... Read More
Drug Department asking for documents to be notarizerd. What does it means? How documents should be notarized?
Notary means a person authorized to perform certain legal formalities, especially to draw up or certify contracts, deeds, and other documents for... Read More